Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,165 | 47 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PREVENTRIC DIAGNOSTICS, INC. | $407.73 | 1 | $0 (2021) |
| Daiichi Sankyo Inc. | $199.36 | 9 | $0 (2024) |
| Novo Nordisk Inc | $69.29 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $66.60 | 5 | $0 (2024) |
| AbbVie Inc. | $54.51 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $39.21 | 3 | $0 (2022) |
| Abbott Laboratories | $37.32 | 2 | $0 (2022) |
| IDORSIA PHARMACEUTICALS US INC | $36.27 | 2 | $0 (2022) |
| PFIZER INC. | $34.39 | 2 | $0 (2022) |
| VBI Vaccine (Delaware) Inc. | $33.24 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $72.33 | 4 | Daiichi Sankyo Inc. ($28.81) |
| 2023 | $146.56 | 8 | Daiichi Sankyo Inc. ($70.31) |
| 2022 | $250.37 | 14 | Daiichi Sankyo Inc. ($81.97) |
| 2021 | $543.28 | 11 | PREVENTRIC DIAGNOSTICS, INC. ($407.73) |
| 2018 | $30.49 | 2 | Abbott Laboratories ($15.66) |
| 2017 | $121.84 | 8 | AbbVie, Inc. ($40.25) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: Iron Deficiency Anemia | ||||||
| 02/14/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: VACCINES | ||||||
| 01/11/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: VACCINES | ||||||
| 08/31/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: VACCINES | ||||||
| 05/23/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: UROLOGY | ||||||
| 04/13/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/30/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/02/2023 | VBI Vaccine (Delaware) Inc. | PreHevbrio (Drug) | Food and Beverage | Cash or cash equivalent | $15.18 | General |
| Category: VACCINES | ||||||
| 01/25/2023 | VBI Vaccine (Delaware) Inc. | PreHevbrio (Drug) | Food and Beverage | Cash or cash equivalent | $18.06 | General |
| Category: VACCINES | ||||||
| 01/05/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/01/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: INSOMNIA | ||||||
| 11/07/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/01/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: INSOMNIA | ||||||
| 10/20/2022 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: WATCHMAN_IC | ||||||
| 09/29/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: VACCINES | ||||||
| 09/28/2022 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Neuromodulation | ||||||
| 09/13/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: DIABETES | ||||||
| 08/26/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/02/2022 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: VACCINES | ||||||
| 03/23/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: VACCINES | ||||||
| 03/16/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Iron Deficiency Anemia | ||||||
| 02/17/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 44 | 5,236 | 21,387 | $775,109 | $241,073 |
| 2022 | 49 | 5,591 | 9,374 | $760,774 | $235,926 |
| 2021 | 47 | 5,601 | 9,849 | $765,782 | $228,364 |
| 2020 | 47 | 5,586 | 10,225 | $762,662 | $201,780 |
All Medicare Procedures & Services
187 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 568 | 1,194 | $234,024 | $99,760 | 42.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 236 | 241 | $30,125 | $18,220 | 60.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 250 | 334 | $45,090 | $17,998 | 39.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 86 | 97 | $38,800 | $14,948 | 38.5% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 12 | 12,000 | $24,300 | $10,587 | 43.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 553 | 777 | $73,815 | $10,169 | 13.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 626 | 1,171 | $23,420 | $9,795 | 41.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 594 | 945 | $72,765 | $9,752 | 13.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 244 | 249 | $9,213 | $7,263 | 78.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 120 | 142 | $11,360 | $5,231 | 46.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 36 | 36 | $7,560 | $4,500 | 59.5% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 508 | 712 | $28,480 | $4,498 | 15.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 203 | 372 | $24,180 | $3,525 | 14.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 127 | 163 | $14,670 | $2,673 | 18.2% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 17 | 17 | $4,250 | $2,431 | 57.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 35 | 39 | $6,825 | $1,844 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $4,736 | $1,775 | 37.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 144 | 177 | $7,080 | $1,347 | 19.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 68 | 68 | $6,732 | $1,287 | 19.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 125 | $5,000 | $1,207 | 24.1% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 12 | 132 | $3,960 | $1,146 | 28.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 26 | 29 | $3,625 | $1,126 | 31.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 30 | 30 | $11,250 | $1,089 | 9.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 58 | 62 | $5,642 | $949.86 | 16.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 23 | 24 | $2,308 | $830.88 | 36.0% |
About Dr. Greg Blakely, MD
Dr. Greg Blakely, MD is a Internal Medicine healthcare provider based in Pinehurst, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962442723.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Greg Blakely, MD has received a total of $1,165 in payments from pharmaceutical and medical device companies, with $72.33 received in 2024. These payments were reported across 47 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,165).
As a Medicare-enrolled provider, Blakely has provided services to 22,014 Medicare beneficiaries, totaling 50,835 services with total Medicare billing of $907,144. Data is available for 4 years (2020–2023), covering 187 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Pinehurst, NC
- Active Since 06/08/2006
- Last Updated 01/24/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962442723
Products in Payments
- BPRO BT AMBULATORY BLOOD PRESSURE MONITORING SYSTEM (Device) $407.73
- INJECTAFER (Drug) $199.36
- SHINGRIX (Biological) $54.38
- QUVIVIQ (Drug) $36.27
- RYBELSUS (Drug) $36.04
- PREVNAR 20 (Biological) $34.39
- PreHevbrio (Drug) $33.24
- BREZTRI (Drug) $25.25
- Androgel (Drug) $25.12
- TROKENDI XR (Drug) $24.17
- OCTRODE (Device) $21.66
- ABILIFY MAINTENA (Drug) $21.37
- WATCHMAN Access System (Device) $17.75
- Wegovy (Drug) $16.86
- Ozempic (Drug) $16.39
- JARDIANCE (Drug) $16.30
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $15.66
- GEMTESA (Drug) $15.42
- Synthroid (Drug) $15.13
- XIFAXAN (Drug) $14.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pinehurst
Michael Soboeiro, Md, MD
Internal Medicine — Payments: $428,147
Sun Moon Kim, M.d, M.D
Internal Medicine — Payments: $32,753
Joan Maradey, Md, MD
Internal Medicine — Payments: $11,388
Brandon Williams, Md, MD
Internal Medicine — Payments: $7,695
Farra Wilson, D.o, D.O
Internal Medicine — Payments: $5,711
Alex Bonnecaze
Internal Medicine — Payments: $4,702